Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;AUTOINJECTOR | 10MG/0.7ML | 0 | MIDAZOLAM | MIDAZOLAM |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2022-08-08 | PRIORITY |
Submissions Property Types
CDER Filings
RAFA LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 216359
[companyName] => RAFA LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"MIDAZOLAM","activeIngredients":"MIDAZOLAM","strength":"10MG\/0.7ML","dosageForm":"INJECTABLE;AUTOINJECTOR","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"08\/08\/2022","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/216359s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"08\/08\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"PRIORITY","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/216359s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/216359Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2022-08-08
)
)